Long-read whole genome sequencing (lrWGS) shows promise as an all-in-one test to detect clinically relevant variants and variants difficult to detect by current short-read whole genome sequencing (srWGS) pipelines. Comparisons between lrWGS and srWGS (or exome sequencing) pipelines will become commonplace as lrWGS is more widely adopted for clinical testing, particularly for individuals not diagnosed by srWGS. However, the sensitivity of lrWGS for detecting variants previously identified and prioritized by clinical srWGS has yet to be assessed.
Benchmarking long-read variant sensitivity across ONT and PacBio platforms using known clinically reported variants in a cohort of critically ill newborns
calendar_today
July 10, 2026
person
Marvin, C. T., Devaney, J. M., Buckingham, K. J., Noya, J., Shively, K. M., Jacques, C., Galey, M., Storz, S. H., Goffena, J., Berlyoung, A. S., Patterson, K. E., Shaffer, T., Zakarian, C., McGee, S. R., Smith, J. D., Lochovsky, L., Gustafson, J. A., Sommerland, O. M., Anderson, K., Love-Nichols, J., Facio, F. M., Robertson, A. V., Rowell, W. J., Lake, J. A., Carroll, A., Miller, D. E., Wei, C. L., McWalter, K., Wenger, T. L., University of Washington Center for Rare Disease Research,, Johnson, B., Bamshad, M. J., Chong, J. X.
domain
medrxiv